✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
圣和化工
首页 › 产品内容 › 埃维特拉韦

埃维特拉韦

CAS 697761-98-1C23H23ClFNO5MW 447.9

埃维特拉韦,CAS 登记号 697761-98-1,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于医药中间体及原料药。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号697761-98-1
分子式C23H23ClFNO5
分子量447.9
LogP5.3
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域医药中间体及原料药
类别医药中间体及原料药

用途与场景

医药中间体及原料药

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 埃维特拉韦 的 CAS 号?

本页已列出 埃维特拉韦 的 CAS 号:697761-98-1,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

埃维特拉韦 一般用在什么产品里?

主要涉及医药中间体及原料药。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

Elvitegravir · CAS 697761-98-1 · C23H23ClFNO5. UNII 4GDQ854U53. Solubility: <0.3 mcg/mL.

Identification

CAS Registry Number697761-98-1
PubChem CID5277135
Molecular formulaC23H23ClFNO5
IUPAC name6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid
UNII (FDA)4GDQ854U53

Computed Descriptors

Molecular Weight447.9
XLogP35.3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass447.1248787
Monoisotopic Mass447.1248787
Topological Polar Surface Area87.1
Heavy Atom Count31
Formal Charge0

Physical & Chemical Properties

Solubility<0.3 mcg/mL

Regulatory Status

GHS notification summary33.3% (1 / 3)

GHS Hazard Classification

GHS notification summary33.3% (1 / 3)
Reported hazard statementsH400 (33.3%), H410 (33.3%), H411 (33.3%), H412 (33.3%)

This chemical does not meet GHS hazard criteria for 33.3% (1 of 3) of reports.

H400 (33.3%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]

Documented Uses

  • Elvitegravir in combination with an HIV protease inhibitor coadministered with ritonavir and with other antiretroviral drug(s) is indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults.
  • Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antiviral Agents; Anti-HIV Agents; Anti-Retroviral Agents; HIV Integrase Inhibitors
  • Avoid St. John's Wort. This herb induces the CYP3A metabolism of elvitegravir. Therefore, it may reduce the serum concentration of elvitegravir and its effectiveness.
  • Take separate from antacids. Take at least 2 hours before or after antacids.
  • Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.
  • Compounds which inhibit or antagonize biosynthesis or actions of integrase.

Synonyms

Elvitegravir; 697761-98-1; GS-9137; JTK-303; Vitekta; GS 9137; JTK 303; elvitegravirum; JTK303; CHEBI:72289; GS9137; 4GDQ854U53; DTXSID101021650; VITEKTA COMPONENT ELVITEGRAVIR; STRIBILD COMPONENT ELVITEGRAVIR; RefChem:58903

Frequently Asked Questions

What are the CAS number and molecular formula of Elvitegravir?

CAS 697761-98-1; molecular formula C23H23ClFNO5; molecular weight — g/mol.

What other names is Elvitegravir known by?

Elvitegravir, 697761-98-1, GS-9137, JTK-303, Vitekta, GS 9137.

Is Elvitegravir classified as hazardous?

33.3% of GHS notifications report no hazard classification (1 of 3).

What are the key physical properties of Elvitegravir?

Solubility: <0.3 mcg/mL.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 埃维特拉韦 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1